Fingerprint
Dive into the research topics of 'A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
Donald C. Goff, J. Steven Lamberti, Andrew C. Leon, Michael F. Green, Alexander L. Miller, Jayendra Patel, Theo Manschreck, Oliver Freudenreich, Steven A. Johnson
Research output: Contribution to journal › Article › peer-review
172
Scopus
citations